SCHEMBL158491

SCHEMBL158491

N#CCCC(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21411550 1.00
SCHEMBL13318957 1.00
SCHEMBL30562964 1.00
SCHEMBL2708260 1.00
SCHEMBL3696195 0.88 SLC1A2 (0.62)
SCHEMBL3696199 0.88 SLC1A2 (0.62)
SCHEMBL8530336 0.86 SLC1A2 (0.60)
SCHEMBL8126946 0.86 SLC1A2 (0.60)
SCHEMBL25662044 0.86 SLC1A2 (0.60)
SCHEMBL25660492 0.85 SLC1A2 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 461 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122031713-A Preparation method and application of linker medicine and antibody-medicine conjugate thereof 乐普生物科技股份有限公司 2026-05-15 CN claimed
EP-4659764-A1 LINKER DRUG, AND PREPARATION METHOD AND USE OF ANTIBODY-DRUG CONJUGATE THEREOF Lepu Biopharma Co., Ltd. (CN) 2025-12-10 EP claimed
WO-2024238632-A2 ASYMMETRIC CIRCULAR TANDEM REPEAT PROTEINS Seattle Children’s Hospital d/b/a Seattle Children’s Research Institute (US) 2024-11-21 WO claimed
WO-2024160176-A1 LINKER DRUG, AND PREPARATION METHOD AND USE OF ANTIBODY-DRUG CONJUGATE THEREOF 上海美雅珂生物技术有限责任公司 2024-08-08 WO claimed
US-20220380425-A1 ANGPTL3 BASED VACCINE FOR THE TREATMENT OF LIVER DISEASE CADILA HEALTHCARE LIMITED (IN) 2022-12-01 US claimed
EP-3993820-A1 ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 Cadila Healthcare Limited (IN) 2022-05-11 EP claimed
WO-2021001804-A1 ANGPTL3 BASED VACCINE FOR THE TREATMENT OF LIVER DISEASE CADILA HEALTHCARE LIMITED (IN) 2021-01-07 WO claimed
US-20200399311-A1 NOVEL PEPTIDE BASED PCSK9 VACCINE ZYDUS LIFESCIENCES LIMITED (IN) 2020-12-24 US claimed
EP-3609532-A1 NOVEL PEPTIDE BASED PCSK9 VACCINE Cadila Healthcare Limited (IN) 2020-02-19 EP claimed
CN-110536696-A PCSK9 vaccine based on new peptide CADILA HEALTHCARE LTD 2019-12-03 CN claimed
WO-2008062457-A2 ANTIDIABETIC COMPOUNDS CADILA HEALTHCARE LIMITED (IN) 2008-05-29 WO claimed
WO-2008031016-A2 HETEROCYCLIC LIGANDS FOR INTEGRIN IMAGING AND THERAPY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-03-13 WO claimed
US-20060135790-A1 Process for the preparation of an alpha-amino carbonyl compound DSM IP ASSETS B.V. (NL) 2006-06-22 US claimed
WO-2005122379-A9 ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY UNIV CALIFORNIA (US) 2006-03-09 WO claimed
US-20060019900-A1 Alpha-4 beta-1 integrin ligands for imaging and therapy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2006-01-26 US claimed
WO-2005122379-A2 ALPHA-4 BETA-1 INTEGRIN LIGANDS FOR IMAGING AND THERAPY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-12-22 WO claimed
EP-1599441-A1 PROCESS FOR THE PREPARATION OF AN ALPHA-AMINO CARBONYL COMPOUND DSM IP Assets B.V. (NL) 2005-11-30 EP claimed
WO-2004078702-A1 PROCESS FOR THE PREPARATION OF AN α-AMINO CARBONYL COMPOUND DSM IP ASSETS B.V. (NL) 2004-09-16 WO claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US claimed
EP-0733374-A2 Cyano-alpha-amino carboxylic acids, and their use in preparing labelled alpha-amino acids RESEARCH DEVELOPMENT CORPORATION OF JAPAN (JP) 1996-09-25 EP claimed